Fate Therapeutics (FATE) Invested Capital (2012 - 2019)
Fate Therapeutics (FATE) posted Invested Capital of $13.9 million for Q3 2019, up 155.77% on a QoQ basis from $5.4 million in Q2 2019, and up 326.84% year-over-year from $3.3 million in Q3 2018.
Fate Therapeutics (FATE) Invested Capital (2012 - 2019) Analysis & Trends
Fate Therapeutics' Invested Capital history runs 8 years deep, the most recent figure standing at $13.9 million for Q3 2019.
- Quarterly Invested Capital rose 326.84% year-over-year to $13.9 million in Q3 2019, while the trailing twelve-month figure through Jun 2020 was $13.9 million (down 7.67% YoY) and the FY2018 annual result came in at $2.4 million, changed N/A from the prior year.
- Invested Capital was $13.9 million for Q3 2019 at Fate Therapeutics, up from $5.4 million in the prior quarter.
- Across five years, Invested Capital topped out at $13.9 million in Q3 2019 and bottomed at $758000.0 in Q1 2018.
- A 5-year average of $5.9 million and a median of $6.0 million in 2015 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2015 — Invested Capital surged 962.85% — and 2018, when it slumped 90.12%.
- Fate Therapeutics' Invested Capital stood at $7.7 million in 2015, then increased by 6.48% to $8.2 million in 2016, then slipped by 6.3% to $7.7 million in 2017, then plunged by 68.22% to $2.4 million in 2018, then soared by 471.45% to $13.9 million in 2019.
- Business Quant data shows FATE's Invested Capital at $13.9 million in Q3 2019, $5.4 million in Q2 2019, and $3.9 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Fate Therapeutics | 302.48 Mn | 302.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 13.93 Mn |
| Jun 30, 2019 | 5.45 Mn |
| Mar 31, 2019 | 3.94 Mn |
| Dec 31, 2018 | 2.44 Mn |
| Sep 30, 2018 | 3.26 Mn |
| Jun 30, 2018 | 2.01 Mn |
| Mar 31, 2018 | 758,000.00 |
| Mar 31, 2017 | 7.67 Mn |
| Dec 31, 2016 | 8.19 Mn |
| Sep 30, 2016 | 8.11 Mn |
| Jun 30, 2016 | 7.97 Mn |
| Mar 31, 2016 | 7.71 Mn |
| Dec 31, 2015 | 7.69 Mn |
| Sep 30, 2015 | 6.49 Mn |
| Jun 30, 2015 | 5.16 Mn |
| Mar 31, 2015 | 3.26 Mn |
| Dec 31, 2014 | 1.54 Mn |
| Sep 30, 2014 | 611,000.00 |
| Jun 30, 2014 | 746,000.00 |
| Mar 31, 2014 | 1.24 Mn |